Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2002, p. 205-209, Vol. 40, No. 1
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.1.205-209.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Internal Medicine,1 Department of Microbiology and Plant Pathology,2 Department of Human Genetics,3 Department of Stomatological Research, University of Pretoria, Pretoria 0002,4 Department of Medical Microbiology, University of Cape Town, Cape Town 7925, South Africa5
Received 23 February 2001/ Returned for modification 13 June 2001/ Accepted 3 October 2001
|
|
|---|
|
|
|---|
Several methods for detecting H. pylori are used at present. Most of these diagnostic tests are performed on gastric biopsy samples, and the bacterium can be identified in these specimens by a urea hydrolysis test, staining techniques, and culturing (14, 38). Both the urease test and microscopic analysis of stained biopsy smears, however, suffer from low sensitivity (10), and conventional plate counting is tedious and time-consuming and usually underestimates the number of these organisms (7). Since invasive methods are expensive, less-invasive methods such as serologic examination of blood and the urea breath test are becoming more popular (47). However, positive results by blood serology do not necessarily allow the delineation of a current active H. pylori infection from a past H. pylori infection, while urea breath tests require expensive, specialized equipment and reagents (5).
Based on the difficulty of culturing H. pylori from sites other than the gastric mucosa (20) and the need for noninvasive diagnostic methods, interest has grown in the use of molecular techniques for detection of this species. The use of gene-specific probes has been described for the detection of H. pylori in biopsy specimens (25, 44), and progress has been made by use of PCR, which provides a specific and highly sensitive means of detecting microbial pathogens in clinical material. PCR assays have detected H. pylori DNA in fresh gastric biopsy specimens (7, 12, 17, 23, 30), in feces (33, 45), in saliva (23, 30), and in dental plaque (3, 7, 8, 11, 41). The detection of H. pylori in dental plaque and saliva suggests that the oral cavity may be an important reservoir for this organism. Many studies have been published recently that support and contradict this theory (2, 4, 7, 8, 11, 24, 31, 34, 35, 37, 39, 41). Most of these studies have used PCR assays on dental plaque and saliva specimens and reported a 0 to 97% incidence of positive samples. As these results are not in agreement with the prevalence of H. pylori infection in the stomach, it is questionable as to whether they represent the real prevalence of this microorganism in the human oral cavity or are artifacts of the methods applied. It has been speculated that the conflicting PCR results obtained concerning H. pylori presence in the oral cavity could in part be due to the use of PCR primers of differing sensitivities and specificities as well as the use of samples from different patient groups (40). Thus, the hypothesis that the oral cavity may be a permanent reservoir of viable H. pylori still remains a controversial issue.
In this study, we report the development of a heminested PCR assay based on the amplification of a specific internal region of the phosphoglucosamine mutase gene (glmM) of H. pylori. We furthermore evaluated the heminested PCR assay for the detection of H. pylori in saliva and dental plaque by comparison with an established PCR assay.
|
|
|---|
DNA extraction. Suspensions of each bacterial strain were prepared in sterile double-distilled water (200 µl) by inoculation of a single bacterial colony from agar plates with a standard loop. The bacterial cells were subsequently subjected to a freeze-thaw lysis procedure. Briefly, bacterial suspensions were frozen at -70°C for 8 min followed by thawing at 40°C for 3 min. These cycles were repeated five times with intermittent vortexing, after which the cellular debris was removed by centrifugation at 10,000 x g for 1 min. The supernatant fluid was recovered and 5 µl of DNA was used as template in the PCRs.
Selection and synthesis of primers. Oligonucleotide primers HPU50 (5'-GAACATGACTACACCAT-3') and HPU25 (5'-TGGTTTGAGGGCGAATC-3') have been described previously (13). These primers yield a 933-bp PCR product of the H. pylori urease B gene. Primers glmMF (5'-CGCGAGCCACAACCCTTTTGAAG-3') and glmMR (5'-CGCGCTCACTTGCAAAGCGCACAC-3') as well as an internal primer, glmMI (5'-GCTTATCCCCATGCACGATATTC-3'), were designed based on the glmM gene sequence reported by Labigne et al. (29). The first PCR step, performed with primers glmMF and glmMR, amplified a 765-bp region of the H. pylori glmM gene, while the size of the final PCR product obtained with primers glmMF and glmMI was 496 bp. The primers were synthesized by MWG-Biotech (Ebersberg, Germany) with automatic DNA synthesizers.
Primer specificity. Oligonucleotide primers glmMF, glmMR, and glmMI were tested for amplification specificity using DNA extracted from a panel of bacterial strains, as indicated in Table 1.
|
View this table: [in a new window] |
TABLE 1. Bacterial strainsa used for testing glmM primer specificity
|
(ii) Single-step PCRs. The PCRs with primers HPU50 and HPU25 were performed as described previously (13). For primer pair glmMF and glmMR, the reactions were subjected to 30 cycles of amplification under the cycle conditions described above. The amplicons were analyzed with 2% (wt/vol) agarose gels, and the sizes of the amplicons were estimated by comparison with 100-bp DNA size markers (Promega).
Sequence determination of PCR amplicons. PCR amplicons were purified from agarose gels using the QIAEXII DNA extraction kit (QIAGEN, Hilden, Germany). DNA sequencing was performed using the ABI PRISM BigDye terminator cycle sequencing ready reaction kit (Perkin-Elmer, Applied Biosystems, Foster City, Calif.) with an Applied Biosystems 377 DNA sequencer. Amplified DNA fragments were sequenced in both orientations using 10 pmol of the appropriate oligonucleotide primers (HPU50, HPU25, glmLF, or glmMR). The sequence data were analyzed with the Sequencing Analysis 3.1 and Sequencing Navigator 1.0.1 programs included in the ABI PRISM software package (Perkin-Elmer, Applied Biosystems). Sequence comparison was subsequently carried out using the BLAST 2.1 software program and the GenBank database.
|
|
|---|
To investigate the specificity of the heminested PCR, the bacterial extracts were subjected to a 10-cycle PCR amplification with primers glmMF and glmMR, and 1 µl of the first-round PCR product was subjected to another 20 cycles of amplification with oligonucleotides glmMF and the nested primer, glmMI. Only the H. pylori strains yielded an amplicon of the expected size (approximately 496 bp) on agarose gel electrophoresis. No similar amplification product was observed from microorganisms other than H. pylori (Table 1 and Fig. 1). However, amplification of a smaller 100-bp fragment from H. pylori isolates was occasionally observed (Fig. 1, lane 13). Because this fragment was only amplified in the presence of H. pylori but was not observed when other bacterial strains were used, we attribute its presence to amplification of this fragment from these organisms rather than amplification of DNA from any other bacteria. We therefore concluded that both the single-step and heminested PCR assays could be used to specifically detect H. pylori DNA sequences.
![]() View larger version (46K): [in a new window] |
FIG. 1. Specific detection of H. pylori by heminested PCR. Shown is agarose gel electrophoresis of amplicons obtained from cells of Arcobacter butzleri, Campylobacter conciscus EF 13144, Campylobacter hyointestinalis NCTC 10608, Campylobacter mucosalis NCTC 1100, Lactobacillus paracasei, Streptococcus cricetus, Streptococcus salivarius, Streptococcus sobrinus, Helicobacter cinaedi NCTC 11611, Helicobacter fennelliae NCTC 11612, H. pylori ATCC 700392, H. pylori isolate 114.90, H. pylori isolate 206.90 sm, H. pylori isolate 228.90, and H. pylori isolate 242.90 Da (lanes 3 to 16, respectively). The arrow indicates the 496-bp amplified fragments obtained only with H. pylori (lanes 12 to 16). Lane 2, negative control (no DNA template). Lanes 1 and 17, 100-bp ladder as a molecular size standard (Promega).
|
H. pylori in saliva and dental plaque samples. Oral specimens from 58 individuals were inoculated onto brain heart infusion agar, but only 8 samples yielded colonies with a morphology resembling that of H. pylori. These cultures were purified, and a limited number of biochemical tests (microaerophilic growth, production of catalase and urease) were performed. No further bacteriological identification of oral cultures was performed.
From this selected group, five isolates were negative in both PCR assays and were thus considered to be non-Helicobacter spp. Only three samples (two saliva and one dental plaque) yielded the expected 933-bp amplification product by PCR using primers HPU50 and HPU25. However, of these three samples, only two were positive by heminested PCR. One of the two saliva samples that tested positive by HPU50-HPU25 PCR was negative in the heminested PCR assay (Fig. 2). On each occasion when PCR was carried out, negative controls were always negative and positive controls were always positive, thereby excluding the possibility of contamination.
![]() View larger version (53K): [in a new window] |
FIG. 2. PCR with primers HPU50 and HPU25 (a) and heminested PCR (b) from a saliva sample, indicating nonspecific amplification following analysis by agarose gel electrophoresis of the amplified products. Lanes: 1, saliva specimen; 2, negative control (no DNA template); 3, H. pylori positive control. 100bp, 100-bp ladder as a molecular size standard (Promega). The sizes of the respective amplicons are indicated by arrows.
|
These results were confirmed in a second independent experiment by PCR amplification of a clinical isolate as well as a type strain of S. epidermidis (ATCC 12228). PCR using HPU50 and HPU25 primers yielded amplicons in both of the samples corresponding to the expected size (933 bp) for amplification of H. pylori-specific DNA. In contrast, no amplification products were observed in the heminested PCR assay (results not shown). Thus, these results served to further confirm the specificity of the heminested PCR assay for H. pylori.
|
|
|---|
Due to the ability of PCR to amplify specifically a gene or segment of a gene directly from a sample, an important factor in evaluating any DNA-based test is the specificity of the DNA sequence chosen for the genes and strains of interest. The primers selected for this study were based on the sequences of the H. pylori glmM gene. Investigation of 60 H. pylori isolates by PCR analysis and DNA sequencing indicated that the gene was present in every isolate (27). Furthermore, the glmM gene has recently been shown to be essential for H. pylori cell growth (15). PCR assays based on the glmM (ureC) gene have been described elsewhere (3, 7, 8) and were applied to the identification of H. pylori from bacterial colonies, gastric biopsies, feces, dental plaque, and oral rinses.
In this report, we have developed and evaluated a novel heminested PCR assay for the detection of H. pylori in clinical samples obtained from the oral cavity. In contrast to conventional nested and heminested PCR procedures (1) which are performed using two rounds of successive amplification consisting of 30 cycles each with an outer and an inner primer pair, respectively, this heminested PCR, based on amplification of the glmM sequence, is performed in a total of 30 cycles. Increasing the number of cycles often leads to the formation of nonspecific amplification products that result from mispriming within nontarget sequences encountered in the sample or by primer-dimer formation (26, 28, 42). The heminested PCR assay increased not only the specificity of the assay but also the detection limit. Only H. pylori strains screened by the PCR assay resulted in visualization of the predicted 496-bp amplified product in ethidium bromide-stained gels. Under the tested parameters, as little as 10 pg of purified chromosomal DNA, equivalent to 5 x 104 bacteria, was detectable by a single, first-round PCR assay. However, heminested PCR amplification enhanced the limit of detection considerably (at least 100-fold), and 0.1 pg of H. pylori DNA (5 x 102 organisms) was detectable in this assay. This is an improvement over an earlier study in which 100 pg of purified chromosomal DNA was needed for detection of H. pylori by PCR on the glmM gene (7).
The applicability of the heminested PCR procedure for screening oral specimens for the occurrence of H. pylori was also evaluated. The same series of saliva and dental plaque specimens were tested by heminested PCR and by a second PCR assay using oligonucleotide primers HPU50 and HPU25 because of their reported specificity in amplifying an H. pylori-specific 933-bp region of the urease B gene (13). The results indicated that one of three specimens found to be positive after amplification with the urease B gene-specific primers tested negative for H. pylori by the heminested PCR approach. Sequencing analyses of the amplicon indicated that it originated from S. epidermidis, a bacterium frequently associated with the oral environment.
These results not only confirm the specificity of the heminested PCR but they also highlight the importance of validating the identity of the amplification product by a second specific and sensitive method. This may be particularly important when clinical specimens are directly screened for the presence of H. pylori. Dental plaque may harbor more than 350 different bacterial species, and H. pylori-like organisms in the microflora may give false-positive PCR results on analysis of plaque material in some patients (36). In this study, the use of a heminested PCR minimized the chance of generating false-positive results, since any nonspecific amplicons produced during the first PCR step should not be able to function as target DNA during the second PCR step due to a lack of complementarity with the inner primer sequence, thereby making confirmation of the product by other procedures such as nucleic acid hybridization or sequencing unnecessary.
The possibility that H. pylori may colonize the oral cavity has attracted considerable attention. The presence of H. pylori in dental plaque of patients both with and without stomach disorders has been investigated by bacterial culture and PCR methods. Most studies have failed to isolate H. pylori by culture from dental plaque of subjects with gastric infection (4, 5, 6). PCR analysis of dental plaque from subjects with gastric infection has yielded more conflicting data, with H. pylori DNA found frequently in some studies (4, 35) but absent or found at extremely low frequencies in other studies (5, 24). In the dental plaque of healthy subjects, culture methods have detected H. pylori at a high frequency in a single study (32), while PCR has only very rarely detected H. pylori at high frequency (4). H. pylori has been detected by PCR in the saliva of symptomatic subjects (23, 31, 39), whereas culture methods have very rarely isolated H. pylori from saliva (19).
The low detection rate obtained in this study (2 of 58 samples) is in agreement with previous reports in which H. pylori was detected in 2 of 124 samples (8) and 0 of 10 samples (7). The low detection rate in this study may have been due to the culturing of oral samples prior to PCR analysis. Culture of H. pylori from patients oral samples has been problematic because currently available culture media for isolation of H. pylori are frequently overgrown by other, faster-growing bacteria, and the prevalence of H. pylori in the oral cavity may be underestimated due to the presence of viable but nonculturable coccoid H. pylori organisms (9). In this regard, PCR assays have a much greater sensitivity, and we believe a greater degree of positivity may have been obtained if DNA were directly isolated from the specimens and then used in the heminested PCR procedure.
In conclusion, we consider the heminested PCR assay to be highly accurate for detection and confirmation of H. pylori infection based on the following reasons. First, PCR products that were positive by electrophoresis were also sequenced, which revealed those sequences were derived from H. pylori cells and not from other helicobacters or bacteria. Secondly, the PCR results could be reproduced by using the facilities of a different laboratory, thus validating the repeatability of the heminested PCR assay. The method could therefore have a potential value for further epidemiological studies for H. pylori-related research.
Funding for this research was provided through the Hepatology Research Fund (A5991-4476), Department of Internal Medicine, University of Pretoria, Pretoria, South Africa.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»